These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17335304)

  • 21. Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities.
    Van Vlaenderen I; Canon JL; Cocquyt V; Jerusalem G; Machiels JP; Neven P; Nechelput M; Delabaye I; Gyldmark M; Annemans L
    Acta Clin Belg; 2009; 64(2):100-12. PubMed ID: 19432022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trastuzumab (herceptin) for early-stage breast cancer.
    Ismael G; Rosa DD; de Azambuja E; Braga S; Piccart-Gebhart M
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):239-56. PubMed ID: 17512447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost-effectiveness of trastuzumab in the treatment of early stages breast cancer patients, in Portugal].
    Macedo A; Monteiro I; Andrade S; Cirrincione A; Ray J
    Acta Med Port; 2010; 23(3):475-82. PubMed ID: 20654267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much will Herceptin really cost?
    Barrett A; Roques T; Small M; Smith RD
    BMJ; 2006 Nov; 333(7578):1118-20. PubMed ID: 17124225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer.
    Plosker GL; Keam SJ
    Drugs; 2006; 66(4):449-75. PubMed ID: 16597163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trastuzumab--mechanism of action and use in clinical practice.
    Hudis CA
    N Engl J Med; 2007 Jul; 357(1):39-51. PubMed ID: 17611206
    [No Abstract]   [Full Text] [Related]  

  • 27. Trastuzumab: is the new evidence revolutionary?
    Munshi A; Singh P; Jalali R
    J Cancer Res Ther; 2006; 2(3):144-6. PubMed ID: 17998695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Her2 and trastuzumab in breast cancer.
    Horton J
    Cancer Control; 2001; 8(1):103-10. PubMed ID: 11176040
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review.
    Tokuda Y; Suzuki Y; Saito Y; Umemura S
    Breast Cancer; 2009; 16(4):295-300. PubMed ID: 19609647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
    Yaal-Hahoshen N; Safra T
    Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
    [No Abstract]   [Full Text] [Related]  

  • 31. Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients?
    Coulson SG; Kumar VS; Manifold IM; Hatton MQ; Ramakrishnan S; Dunn KS; Purohit OP; Bridgewater C; Coleman RE
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):289-93. PubMed ID: 20347281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer.
    Baselga J; Perez EA; Pienkowski T; Bell R
    Oncologist; 2006; 11 Suppl 1():4-12. PubMed ID: 16971734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Very small breast cancer, HER2 positive, and trastuzumab in adjuvant treatment].
    Vyzula R
    Klin Onkol; 2010; 23(1):21-4. PubMed ID: 20192070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trastuzumab: updates and future issues.
    Toi M; Horiguchi K; Bando H; Saji S; Chow LW
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():94-9. PubMed ID: 16273357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trastuzumab for early breast cancer: current status and future directions.
    Dinh P; de Azambuja E; Piccart-Gebhart MJ
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):707-17. PubMed ID: 17982412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HER2 testing in breast cancer].
    Yoshimura K
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():275-80. PubMed ID: 17682167
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of trastuzumab for the treatment of early stage breast cancer.
    Braga S; dal Lago L; Bernard C; Cardoso F; Piccart M
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1153-64. PubMed ID: 16925482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trastuzumab in the adjuvant treatment of breast cancer.
    Svetlovska D; Mardiak J; Kristova V
    Bratisl Lek Listy; 2007; 108(2):100-3. PubMed ID: 17685010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer.
    Morris SR; Carey LA
    Oncology (Williston Park); 2006 Dec; 20(14):1763-71; discussion 1771-2, 1774-6. PubMed ID: 17263127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lapatinib: new directions in HER2 directed therapy for early stage breast cancer.
    Jo Chien A; Rugo HS
    Cancer Treat Res; 2009; 151():197-215. PubMed ID: 19593514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.